YORW:NASDAQThe York Water Company Analysis
Data as of 2026-09-01 - not real-time
$33.91
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The York Water Company is priced at $33.91 and its moving averages line up in bullish order, the shorter sitting above the longer. It has gained 10.6% over the past 30 days. Momentum indicators put RSI at 61.9 (approaching overbought) with MACD reading bearish. Price has been bracketed by support at $30.54 and resistance at $34.81.
On valuation the read is fair — earnings multiple of 21.1 versus a 19.4 sector average, in line with the peer group. Sell-side targets cluster 8.6% below the current quote. Revenue is growing at 22.5% on a 28.5% profit margin. The 2.68% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 18.6%, a beta of -0.14 and a maximum drawdown of 15.0%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
On valuation the read is fair — earnings multiple of 21.1 versus a 19.4 sector average, in line with the peer group. Sell-side targets cluster 8.6% below the current quote. Revenue is growing at 22.5% on a 28.5% profit margin. The 2.68% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 18.6%, a beta of -0.14 and a maximum drawdown of 15.0%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
YORK, Pa., Aug. 06, 2026 GLOBE NEWSWIRE -- The York Water Company's NASDAQ:YORW President, JT Hand, announced the...York Water is one of the oldest U.S. utilities companies. Learn how to invest and see if it's a good fit for your...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 31.57
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 21.1 versus sector average of 19.4
- Trading above the 200-day average of 31.57
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 21.1 versus sector average of 19.4
- Analyst targets imply -8.6% versus the current price
- Profit margin of 28.5% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth22.50%
Profit Margin28.53%
P/E Ratio21.1
ROE9.00%
ROA2.86%
Debt/Equity64.57
P/B Ratio2.0
Op. Cash Flow$33.5M
Free Cash Flow$-20914624
Industry P/E19.4
Technical Analysis
TrendBullish
RSI61.9
Support$30.54
Resistance$34.81
MA 20$33.24
MA 50$31.82
MA 200$31.57
MACDBearish
VolumeDecreasing
Fear & Greed Index92.16
Valuation
Fair Value$34.02
Target Price$31.00
Upside/Downside-8.57%
GradeFair
TypeBlend
Dividend Yield2.68%
Risk Assessment
Beta-0.14
Volatility18.58%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.